* Penumbra Inc PEN.N reported quarterly adjusted earnings
of 85
cents per share for the quarter ended January 1, higher than
the same quarter last year, when the company reported EPS of 67
cents. The mean expectation of seventeen analysts for the
quarter was for earnings of 69 cents per share. Wall Street
expected results to range from 50 cents to 85 cents per share.
* Revenue rose 11.1% to $301.04 million from a year ago;
analysts
expected $297.41 million.
* Penumbra Inc's reported EPS for the quarter was 75 cents.
* The company reported quarterly net income of $29.53
million.
* Penumbra Inc shares had risen by 7.9% this quarter and
lost 16.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 2.3%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 7
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Penumbra Inc is
232.00
This summary was machine generated from LSEG data October 31 at
02:59 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.69 0.85 Beat
Jun. 30 2024 0.56 0.64 Beat
Mar. 31 2024 0.38 0.41 Beat
Dec. 31 2023 0.70 0.76 Beat